NeoGenomics

Selected news for the company - NeoGenomics, collected since 5/2020. This company shares news with Medical Research, Zacks Investment Research, Needham & Company, Goldman Sachs and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
10/16/2021 NeoGenomics (NASDAQ:NEO) Shares Gap Up to $42.00 - Mayfield Recorder Mayfield Recorder NeoGenomics, Inc. (NASDAQ:NEO)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $42.00, but opened at $43.71. NeoGenomics shares last traded at $43.94, with a volume of 1,215 shares.Several equities analysts recently commented on the company. Morgan Stanley reduced their price target on NeoGenomics from $64.00 to $58.00 and set an “overweight” rating on the stock in a research ...
10/16/2021 Raymond James Upgrades NeoGenomics (NASDAQ:NEO) to Outperform dispatchtribunal.com ... of 22.18% from the stock’s previous close. Other analysts also recently issued reports about the stock. Needham & Company LLC reissued a “buy” rating and issued a $55.00 price target on shares of NeoGenomics in a research note on Monday, August 9th. Zacks Investment Research raised shares of NeoGenomics from a “sell” rating to a “hold” rating in a research note on Tuesday, August 17th. Benchmark boosted ...
10/16/2021 NeoGenomics (NASDAQ:NEO) Raised to “Outperform” at Raymond James theenterpriseleader.com ... from the stock’s current price. NEO has been the subject of a number of other reports. Needham & Company LLC reissued a “buy” rating and issued a $55.00 price objective on shares of NeoGenomics in a research note on Monday, August 9th. Benchmark raised their target price on shares of NeoGenomics from $46.00 to $50.00 and gave the company a “buy” rating in a research note on Thursday ...
10/16/2021 Zacks: Brokerages Expect NeoGenomics, Inc. (NASDAQ:NEO) Will Announce Earnings of -$0.08 Per Share baseballnewssource.com Wall Street analysts expect that NeoGenomics, Inc. (NASDAQ:NEO) will report earnings of ($0.08) per share for the current fiscal quarter, according to Zacks . Three analysts have issued estimates for NeoGenomics’ earnings. The highest EPS estimate is ($0.05) and the lowest is ($0.10). NeoGenomics reported earnings per share of $0.06 in the same quarter last year, which suggests a negative year-over-year growth rate of 233.3%. The company ...
10/16/2021 Analysts Anticipate NeoGenomics, Inc. (NASDAQ:NEO) Will Announce Earnings of -$0.08 Per Share dispatchtribunal.com Equities analysts forecast that NeoGenomics, Inc. (NASDAQ:NEO) will report earnings of ($0.08) per share for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for NeoGenomics’ earnings, with the lowest EPS estimate coming in at ($0.10) and the highest estimate coming in at ($0.05). NeoGenomics posted earnings per share of $0.06 during the same quarter last year, which would suggest a negative year-over-year growth ...
10/15/2021 NeoGenomics, Inc. (NASDAQ:NEO) Given Average Rating of “Buy” by Analysts com-unik.info ... that have updated their coverage on the stock in the last year is $52.83. A number of equities analysts have recently issued reports on NEO shares. Benchmark upped their target price on shares of NeoGenomics from $46.00 to $50.00 and gave the stock a “buy” rating in a research report on Thursday, August 26th. Needham & Company LLC reiterated a “buy” rating and set a $55.00 target price on ...
10/15/2021 NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Recommendation of “Buy” from Analysts thelincolnianonline.com ... covered the stock in the last year is $52.83. Several analysts recently weighed in on the stock. Needham & Company LLC reiterated a “buy” rating and issued a $55.00 price target on shares of NeoGenomics in a report on Monday, August 9th. Morgan Stanley lowered their price objective on NeoGenomics from $64.00 to $58.00 and set an “overweight” rating for the company in a research report on Monday, August ...
10/15/2021 Gulfshore Business Daily: Oct. 15 gulfshorebusiness.com Lead Photo: Seagate completes NeoGenomics ’ global headquarters. Details below.COLLIER COUNTY COMMISSIONERS DECLINE PLAN FOR FOOD TRUCK PARK IN ISLE OF CAPRICollier County commissioners, acting as the Board of Zoning Appeals this week, unanimously overturned a staff recommendation that would have allowed a proposed food truck park to be built on Isles of Capri. The proposed local development on more than 2 acres of land zoned C-3 ...
10/15/2021 NeoGenomics – Consensus Indicates Potential 34.4% Upside directorstalkinterviews.com ... with Inivata Limited; and has collaboration with Elevation Oncology to expand genomic testing for NRG1 fusions across solid tumors. The company was founded in 2001 and is headquartered in Fort Myers, Florida.This article NeoGenomics – Consensus Indicates Potential 34.4% Upside first appeared on DirectorsTalk Interviews ...
10/15/2021 Ensign Peak Advisors Inc Grows Position in NeoGenomics, Inc. (NASDAQ:NEO) American Banking News Ensign Peak Advisors Inc boosted its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 19.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 103,000 shares of the medical research company’s stock after purchasing an additional 16,800 shares during the period. Ensign Peak Advisors Inc owned approximately 0.08% of NeoGenomics worth $4,653,000 at the end ...
10/15/2021 Ensign Peak Advisors Inc Grows Position in NeoGenomics, Inc. (NASDAQ:NEO) Dakota Financial News Ensign Peak Advisors Inc boosted its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 19.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 103,000 shares of the medical research company’s stock after purchasing an additional 16,800 shares during the period. Ensign Peak Advisors Inc owned approximately 0.08% of NeoGenomics worth $4,653,000 at the end ...
10/15/2021 NeoGenomics (NASDAQ:NEO) Upgraded to Outperform at Raymond James baseballnewssource.com Raymond James upgraded shares of NeoGenomics (NASDAQ:NEO) from a market perform rating to an outperform rating in a report issued on Thursday morning, Price Targets.com reports. Raymond James currently has $53.00 price objective on the medical research company’s stock.Several other brokerages have also recently issued reports on NEO. Benchmark raised their price objective on NeoGenomics from $46.00 to $50.00 and gave the stock a buy rating in ...
10/15/2021 NeoGenomics (NASDAQ:NEO) Upgraded to Outperform at Raymond James - The Cerbat Gem thecerbatgem.com Raymond James upgraded shares of NeoGenomics (NASDAQ:NEO) from a market perform rating to an outperform rating in a research report released on Thursday, Price Targets.com reports. Raymond James currently has $53.00 target price on the medical research company’s stock.A number of other brokerages have also recently weighed in on NEO. Morgan Stanley dropped their price objective on shares of NeoGenomics from $64.00 to $58.00 and set an ...
10/15/2021 American Capital Management Inc. Has $10.69 Million Stake in NeoGenomics, Inc. (NASDAQ:NEO) slatersentinel.com American Capital Management Inc. increased its position in NeoGenomics, Inc. (NASDAQ:NEO) by 0.7% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 236,591 shares of the medical research company’s stock after purchasing an additional 1,723 shares during the period. American Capital Management Inc.’s holdings in NeoGenomics were worth $10,687,000 at the end of the most recent reporting period. A ...
10/15/2021 American Capital Management Inc. Increases Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - Mayfield Recorder Mayfield Recorder American Capital Management Inc. increased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 0.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 236,591 shares of the medical research company’s stock after purchasing an additional 1,723 shares during the period. American Capital Management Inc. owned 0.19% of NeoGenomics worth $10,687,000 as of its most recent ...
10/14/2021 NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021 portlandnews.net FT. MYERS, FL / ACCESSWIRE / October 13, 2021 / NeoGenomics , Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to release its third quarter 2021, financial results on Thursday, November 4, 2021.The Company has scheduled a webcast and conference call to discuss their third quarter results on Thursday, November 4, 2021 at 8:30 AM EDT. Interested investors should dial ...
10/14/2021 NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021 illinoisintelligencer.com FT. MYERS, FL / ACCESSWIRE / October 13, 2021 / NeoGenomics , Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to release its third quarter 2021, financial results on Thursday, November 4, 2021.The Company has scheduled a webcast and conference call to discuss their third quarter results on Thursday, November 4, 2021 at 8:30 AM EDT. Interested investors should dial ...
10/14/2021 The Ridgway Record ridgwayrecord.com FT. MYERS, FL NeoGenomics , Inc. ( NASDAQ:NEO ), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to release its third quarter 2021, financial results on Thursday, November 4, 2021.The Company has scheduled a webcast and conference call to discuss their third quarter results on Thursday, November 4, 2021 at 8:30 AM EDT. Interested investors should dial (888) 506-0062 (domestic) and ...
10/14/2021 NeoGenomics (NASDAQ:NEO) Lifted to ‚ÄúOutperform‚Äù at Raymond James American Banking News ... Äúmarket perform‚Äù rating to an ‚Äúoutperform‚Äù rating in a research report issued on Thursday, The Fly reports.Other research analysts also recently issued research reports about the company. Zacks Investment Research upgraded NeoGenomics from a ‚Äúsell‚Äù rating to a ‚Äúhold‚Äù rating in a research note on Tuesday, August 17th. Benchmark raised their target price on NeoGenomics from $46.00 to $50.00 and gave the stock a ‚Äúbuy ...
10/14/2021 Upgrades and Downgrades for Thursday, 10/14 tradesoftheday.com ... Overweight - National Vision (EYE) upgraded by Morgan Stanley from Equal Weight to Overweight - Wipro (WIT) upgraded by Morgan Stanley from Underweight to Equal Weight - Chemtrade Logistics (CGIFF) upgraded by Desjardins from Hold to Buy - NeoGenomics (NEO) upgraded by Raymond James from Market Perform to Outperform - Bank of Queensland (BKQNY) upgraded by Citi from Neutral to Buy - Chorus (CHRYY) upgraded by UBS from Sell to Neutral - Pipestone Energy (BKBEF) upgraded by ...